243 related articles for article (PubMed ID: 33175607)
1. Long non-coding RNA IGF2-AS represses breast cancer tumorigenesis by epigenetically regulating IGF2.
Zhang Y; Yan H; Jiang Y; Chen T; Ma Z; Li F; Lin M; Xu Y; Zhang X; Zhang J; He H
Exp Biol Med (Maywood); 2021 Feb; 246(4):371-379. PubMed ID: 33175607
[TBL] [Abstract][Full Text] [Related]
2. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
[TBL] [Abstract][Full Text] [Related]
3. The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications.
Vennin C; Spruyt N; Robin YM; Chassat T; Le Bourhis X; Adriaenssens E
Cancer Lett; 2017 Jan; 385():198-206. PubMed ID: 27780718
[TBL] [Abstract][Full Text] [Related]
4. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway.
Liu W; Zhan J; Zhong R; Li R; Sheng X; Xu M; Lu Z; Zhang S
Technol Cancer Res Treat; 2021; 20():1533033821990074. PubMed ID: 33641529
[TBL] [Abstract][Full Text] [Related]
6. CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism.
Ellis BC; Graham LD; Molloy PL
Biochim Biophys Acta; 2014 Feb; 1843(2):372-86. PubMed ID: 24184209
[TBL] [Abstract][Full Text] [Related]
7. MEG3 overexpression inhibits the tumorigenesis of breast cancer by downregulating miR-21 through the PI3K/Akt pathway.
Zhu M; Wang X; Gu Y; Wang F; Li L; Qiu X
Arch Biochem Biophys; 2019 Jan; 661():22-30. PubMed ID: 30389444
[TBL] [Abstract][Full Text] [Related]
8. Curcumin inhibits urothelial tumor development by suppressing IGF2 and IGF2-mediated PI3K/AKT/mTOR signaling pathway.
Tian B; Zhao Y; Liang T; Ye X; Li Z; Yan D; Fu Q; Li Y
J Drug Target; 2017 Aug; 25(7):626-636. PubMed ID: 28286973
[TBL] [Abstract][Full Text] [Related]
9. 3,6-Dihydroxyflavone Suppresses Breast Carcinogenesis by Epigenetically Regulating miR-34a and miR-21.
Peng X; Chang H; Gu Y; Chen J; Yi L; Xie Q; Zhu J; Zhang Q; Mi M
Cancer Prev Res (Phila); 2015 Jun; 8(6):509-17. PubMed ID: 25784176
[TBL] [Abstract][Full Text] [Related]
10. LncRNA IGF2-AS promotes endometriosis progression through targeting miR-370-3p/IGF2 axis and activating PI3K/AKT/mTOR signaling pathway.
Jin X; Feng J; Cheng X
J Assist Reprod Genet; 2022 Dec; 39(12):2699-2710. PubMed ID: 36508036
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inhibition of miR-663b by long non-coding RNA HOTAIR promotes pancreatic cancer cell proliferation via up-regulation of insulin-like growth factor 2.
Cai H; An Y; Chen X; Sun D; Chen T; Peng Y; Zhu F; Jiang Y; He X
Oncotarget; 2016 Dec; 7(52):86857-86870. PubMed ID: 27895308
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of long non-coding RNA RP11-708H21.4 is associated with poor prognosis for colorectal cancer and promotes tumorigenesis through regulating AKT/mTOR pathway.
Sun L; Jiang C; Xu C; Xue H; Zhou H; Gu L; Liu Y; Xu Q
Oncotarget; 2017 Apr; 8(17):27929-27942. PubMed ID: 28427191
[TBL] [Abstract][Full Text] [Related]
13. YBX1/lncRNA SBF2-AS1 interaction regulates proliferation and tamoxifen sensitivity via PI3K/AKT/MTOR signaling in breast cancer cells.
Hussain SA; Venkatesh T
Mol Biol Rep; 2023 Apr; 50(4):3413-3428. PubMed ID: 36754932
[TBL] [Abstract][Full Text] [Related]
14. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2.
Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C
J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262
[TBL] [Abstract][Full Text] [Related]
16. STX3 represses the stability of the tumor suppressor PTEN to activate the PI3K-Akt-mTOR signaling and promotes the growth of breast cancer cells.
Nan H; Han L; Ma J; Yang C; Su R; He J
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1684-1692. PubMed ID: 29408595
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of BAG‑1 in T47D cells promotes resistance to tamoxifen via activation of the PI3K/Akt/mTOR signaling pathway.
Lu S; Du Y; Cui F; Feng X; Ma Y; Liu H
Oncol Rep; 2019 Mar; 41(3):1901-1910. PubMed ID: 30747221
[TBL] [Abstract][Full Text] [Related]
18. miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling.
Gebeshuber CA; Martinez J
Oncogene; 2013 Jul; 32(27):3306-10. PubMed ID: 22926517
[TBL] [Abstract][Full Text] [Related]
19. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.
Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9978-9987. PubMed ID: 31799667
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA Circ_0000442 acts as a sponge of MiR-148b-3p to suppress breast cancer via PTEN/PI3K/Akt signaling pathway.
Zhang XY; Mao L
Gene; 2021 Jan; 766():145113. PubMed ID: 32891771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
